脂质体
药物输送
靶向给药
化学
药品
毒品携带者
药理学
阿霉素
纳米颗粒
骨肉瘤
体内
纳米载体
药代动力学
癌症研究
医学
生物物理学
体内分布
剂型
作者
Wenqing Liang,Yongqiang Dong,Ruyi Shao,Songou Zhang,Xudong Wu,Xiaogang Huang,Bin Sun,Bin Zeng,Jiayi Zhao
标识
DOI:10.1080/1061186x.2021.2023160
摘要
Osteosarcoma (OS) is one of the most common primary bone malignancies in children and adolescents. The toxicity to healthy tissues from conventional therapeutic strategies, including chemotherapy and radiotherapy, and drug resistance, severely affect OS patients' quality of life and cancer-specific outcomes. Many efforts have been made to develop various nanomaterial-based drug delivery systems with specific properties to overcome these limitations. Among the developed nanocarriers, liposomes are the most successful and promising candidates for providing targeted tumor therapy and enhancing the safety and therapeutic effect of encapsulated agents. Liposomes have low immunogenicity, high biocompatibility, prolonged half-life, active group protection, cell-like membrane structure, safety, and effectiveness. This review will discuss various nanomaterial-based carriers in cancer therapy and then the characteristics and design of liposomes with a particular focus on the targeting feature. We will also summarize the recent advances in the liposomal drug delivery system for OS treatment in preclinical and clinical studies.
科研通智能强力驱动
Strongly Powered by AbleSci AI